0.0907-The manifestation of Gangrene in the Hippocratic corpus (Aletra, Ann Vasc Surg).pdf | 388.41Kb | June 26 2009 |
110.0906-1 The integration of vascular biology and vascular disease diagnosis and intervention. Editorial (Powell, ejves).pdf | 250.62Kb | June 26 2009 |
110.0906-2 Molecular pathology in vulnerable carotid plaques, correlations with FDG-PET (Graebe, ejves).pdf | 642.80Kb | June 26 2009 |
110.0906-3 Contrast carotid US for detection of unstable plaques with neoangiogenesis. Pilot study (Giannoni, ejves).pdf | 2.33Mb | June 26 2009 |
110.0906-4 Functional imaging of atherosclerosis to advance vascular biology (Sakalihasan, ejves).pdf | 316.27Kb | June 26 2009 |
131.0907-Cigarette smoking, an undertreated RF for CVD (Erhardt, Atherosclerosis).pdf | 827.14Kb | June 26 2009 |
214.0906-Myocardial scars are an underestimated CV burden in patients with ICA stenosis (Bruder, CVD).pdf | 498.31Kb | June 26 2009 |
222.0906-Facilities available in French hospitals treating acute stroke, comparison with ... (Leys, J Neurol).pdf | 375.03Kb | October 9 2009 |
233.0907-Unilateral vs bilateral MCA detection of right-to-left shunt by power M-mode TCD (Jesurum, J Neuroimaging).pdf | 404.71Kb | June 26 2009 |
243.0905Epub-Determinants of HITS in patients with atherosclerotic ICA plaques (Telman, ejves) + Commentaire Wisselink.pdf | 334.96Kb | June 26 2009 |
252.0906Epub-ACST2 (CEA vs CAS), Rationale (Halliday, ejves).pdf | 277.05Kb | June 26 2009 |
255.0906-Long-term outcome in patients not suitable for surgery and randomised in CAVATAS (Ederle, CVD).pdf | 345.04Kb | June 26 2009 |
255.0907-Complications during waiting time for CEA (Randall, Ann Vasc Surg).pdf | 448.60Kb | June 26 2009 |
259s.0906-Incidence and RF for IC atherosclerotic stroke. Northern Manhattan Stroke Study (Rincon, CVD).pdf | 363.16Kb | June 26 2009 |
259s.0906-Statins for asymptomatic MCA stenosis. Regression of Cerebral Artery Stenosis Study (Mok, CVD).pdf | 411.46Kb | June 26 2009 |
262.0907-US velocity criteria for vertebral origin stenosis (Koch, J Neuroimaging).pdf | 437.28Kb | June 26 2009 |
263.0907-Quantitative MRA in the evaluation of the subclavian steal Sdr (Bauer, J Neuroimaging).pdf | 432.88Kb | June 26 2009 |
263.0907-Variant of subclavian steal Sdr in the setting of ipsilateral CCA occlusion, case report (Tummala, J Neuroimaging).pdf | 403.16Kb | June 26 2009 |
310e.0906Epub-1 Prevalence of (A)Symptomatic PAD and value of ABI to stratify CV risk. REGICOR (Ramos, ejves).pdf | 364.37Kb | June 26 2009 |
310e.0906Epub-2 Prevalence of (A)Symptomatic PAD, additional value of ABI on CV risk stratification. Commentary (Poldermans, ejves).pdf | 265.67Kb | June 26 2009 |
315.0906-AHA Recommendations for clinical exercise laboratories (Myers, Circulation).pdf | 1.55Mb | June 26 2009 |
331.0907-Vascular protection in PAD. SR and modelling study (Criqui, Heart).pdf | 455.22Kb | June 26 2009 |
373d.0906-Analysis of cost-effectiveness of screening danish men aged 65 for AAA (Ehlers, bmj).pdf | 597.73Kb | June 26 2009 |
373d.0906-Screening for AAA. Editorial (Buxton, bmj).pdf | 448.84Kb | June 26 2009 |
373d.0906-Screening men for AAA, 10 yr mortality and cost-effectiveness results - MASS (Thompson, bmj).pdf | 576.69Kb | June 26 2009 |
373sf.0906Epub-Epidemiology, Aetiology, Risk of rupture and Tt of AAA, Does sex matter (Grootenboer, ejves).pdf | 400.07Kb | June 26 2009 |
376m.0906-Rosiglitazone reduces development and rupture of experimental AAA (Jones, Circulation).pdf | 1.09Mb | June 26 2009 |
387.0907-AAA tuberculeux, cas clinique et revue de la littérature (Lefranc, Rev Med Int).pdf | 553.89Kb | June 26 2009 |
420.0907-Immunopathologie des artérites primitives des gros vaisseaux (Arnaud, Rev Med Int).pdf | 570.77Kb | June 26 2009 |
610.0906-Living near major traffic road and risk of DVT (Baccarelli, Circulation).pdf | 445.39Kb | June 26 2009 |